Clinical Scorecard: A Diagnostic Approach for Obstructive Sleep Apnea Utilizing an Artificial Immune System and Logistic Regression: Insights from a Taiwanese Case Study
At a Glance
Category
Detail
Condition
Obstructive Sleep Apnea (OSA)
Key Mechanisms
Partial or complete collapse of the upper airway during sleep leading to intermittent cessation of breath and decreased oxygenation.
Target Population
Adults aged 24−69 years with suspected OSA symptoms.
Care Setting
Sleep Center of Taipei Medical University Hospital
Key Highlights
OSA is under-diagnosed and under-treated due to lack of effective diagnostic tools.
Polysomnography (PSG) is the gold standard but has limitations in accessibility and patient compliance.
Home Sleep Testing (HST) offers a less intrusive and cost-effective alternative.
A risk prediction model using AIS and LR can enhance diagnostic accuracy with simple clinical data.
The study included 3,345 adult patients based on clinical symptoms and physical measurements.
Guideline-Based Recommendations
Diagnosis
Utilize PSG for definitive diagnosis of OSA.
Consider Home Sleep Testing (HST) combined with screening questionnaires for preliminary assessment.
Management
Develop personalized treatment plans based on Apnea-Hypopnea Index (AHI) values.
Monitoring & Follow-up
Regular assessment of AHI to evaluate OSA severity and treatment efficacy.
Risks
Increased risk of cardiovascular and metabolic diseases associated with untreated OSA.
Patient & Prescribing Data
Adults with suspected OSA based on clinical symptoms.
Incorporate physiological characteristics and symptom data for improved diagnostic models.
Clinical Best Practices
Implement simple screening tools to identify high-risk individuals for OSA.
Promote awareness of sleep-disordered breathing symptoms among patients.
